MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Report Buyer Ltd
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Bosimilars Market Expected to be Worth US$ 19.4 Billion by 2014 Finds Report Buyer - ReportBuyer.com, the online destination for business intelligence for major industry sectors, has added a new report
Global Bosimilars Market Expected to be Worth US$ 19.4 Billion by 2014 Finds Report Buyer

 

NewswireToday - /newswire/ - London, United Kingdom, 2010/03/25 - ReportBuyer.com, the online destination for business intelligence for major industry sectors, has added a new report.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The report “Biosimilars: A Growing Market” provides a comprehensive review of the current and future market for biosimilar products.

The approaching expiry of numerous patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created many opportunities in the global biosimilars market. The global biosimilars market is expected to be worth US$19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The biosimilars market is segmented into peptides, recombinant glycosylated proteins, and recombinant non-glycosylated proteins.

Although a number of major companies have significant biological capabilities, few apart from Novartis have yet clearly developed strategies to compete in the biosimilars market.

Since Sandoz pioneered the development of biosimilar drugs in 2001 there has been a steady breakdown of regulatory resistance. However, there are considerable entry barriers hindering companies that wish to enter this field of therapeutics.

Some key findings from the report include:

• Few companies apart from Novartis have yet clearly developed strategies to compete in the biosimilars market.

• The biosimilars market segment is poorly developed but is expected to become a significant commercial segment capturing a healthy percentage share of the biologicals market.

• Many forecasts of the biosimilars market are over-optimistic, and assume a rapid resolution of the legislative impasse in the US and overlook the strength of Amgen’s patent position with respect to epoetin alfa.

• Assuming a later passing of US legislation the value of the biosimilars market segment will continue to be dominated by European sales revenues in 2012, and this is likely to account for about 0.6% of the fast-growing biologicals market.

• The anti-TNF segment offers the best commercial opportunity with the three leading products all likely to face competition from biosimilars in Europe by 2016.

Report Buyer is the independent online store for global business information. The website now lists more than 120,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Global Bosimilars Market Expected to be Worth US$ 19.4 Billion by 2014 Finds Report Buyer

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: ReportBuyer.com 
+44 (0) 207 060 7474 press[.]reportbuyer.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Report Buyer Ltd / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Frost & Sullivan Analyzes the Future of Adhesion Prevention Products in the US and EU5
FORA Auto Temperature Measurement Station Provides Protection During COVID-19
TPEs Introduces A Range of TPE-compounds for Direct Contact with Blood and Body Fluid Applications in the Medical Sector
Safran and Segula Technologies Continue to Support the Fight Against Covid-19 by Adapting Decathlon’s Easybreath Subea Mask for Use in Hospitals
Bruker Partners with ANPC to Support Major New Frontline Response to Combat the COVID-19 Threat
Ventilator Challenge UK Consortium
MadgeTech Introduces The VTMS Wireless Vaccine Temperature Monitoring System
Florida Biodiesel, Inc. Has Developed A COVID-19 Disinfectant Generator
Bruker Introduces Updated B.I.QUANT-UR™ Module for Fully Validated Metabolite Quantification in Urine Using NMR
SCHOTT Extends SyriQ BioPure® Syringe Format to Enable Optimized Administration
Hand Hygiene Market Will Reach .98 Billion in the US and EU5 with High Adoption of Gamification Finds Frost & Sullivan
Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe Finds Frost & Sullivan
Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™
Withings Launches ScanWatch - the First Hybrid Smartwatch to Combine Medical Grade Electrocardiogram and Sleep Apnea Detection
Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)